Evidence map›Paper›PMID 35209204›Full record

ReviewMolecules (Basel, Switzerland)2022

Cysteine as a Multifaceted Player in Kidney, the

Maria João Correia, António B Pimpão, Dalila G F Fernandes, Judit Morello, Catarina O Sequeira, Joaquim Calado, Alexandra M M Antunes, Manuel S Almeida, Patrícia Branco, Emília C Monteiro and 3 more

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 37 citations in OpenAlex.

  1. The Chronic Elevated Consumption ofInternational journal of molecular sciences · 2026
    Article
  2. Unveiling the Metabolic Milieu of Tertiary Lymphoid Expansion.Journal of the American Society of Nephrology : JASN · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Maria João CorreiaCEDOC, NOVA Medical School, Universidade Nova de Lisboa, 1169-056 Lisboa, Portugal.
António B PimpãoCEDOC, NOVA Medical School, Universidade Nova de Lisboa, 1169-056 Lisboa, Portugal.ORCID 0000-0002-6672-5747
Dalila G F FernandesInstituto de Tecnologia Química e Biológica António Xavier (ITQB NOVA), 2780-157 Oeiras, Portugal.ORCID 0000-0002-6013-0152
Judit MorelloCEDOC, NOVA Medical School, Universidade Nova de Lisboa, 1169-056 Lisboa, Portugal.
Catarina O SequeiraCEDOC, NOVA Medical School, Universidade Nova de Lisboa, 1169-056 Lisboa, Portugal.
Joaquim CaladoCentre for Toxicogenomics and Human Health (ToxOmics), Genetics, Oncology and Human Toxicology, Nova Medical School/Faculdade de Ciências Médicas, Universidade Nova de Lisboa, 1169-056 Lisboa, Portugal.
Alexandra M M AntunesCentro de Química Estrutural, Institute of Molecular Sciences, Instituto Superior Técnico, 1049-001 Lisboa, Portugal.ORCID 0000-0003-1827-7369
Manuel S AlmeidaCEDOC, NOVA Medical School, Universidade Nova de Lisboa, 1169-056 Lisboa, Portugal.
Patrícia BrancoCEDOC, NOVA Medical School, Universidade Nova de Lisboa, 1169-056 Lisboa, Portugal.
Emília C MonteiroCEDOC, NOVA Medical School, Universidade Nova de Lisboa, 1169-056 Lisboa, Portugal.
João B VicenteInstituto de Tecnologia Química e Biológica António Xavier (ITQB NOVA), 2780-157 Oeiras, Portugal.ORCID 0000-0001-5244-8059
Jacinta SerpaCEDOC, NOVA Medical School, Universidade Nova de Lisboa, 1169-056 Lisboa, Portugal.ORCID 0000-0002-1548-5907
Sofia A PereiraCEDOC, NOVA Medical School, Universidade Nova de Lisboa, 1169-056 Lisboa, Portugal.ORCID 0000-0002-8456-9995
Universidade Nova de Lisboa · PTHospital de Santa Cruz · PTInstituto de Biologia Experimental e Tecnológica · PTInstitut des Sciences Moléculaires · FRUnidade Local de Saúde de São José · PT

Funding

Fundação para a Ciência e Tecnologia PD/BD/135484/2018Fundação para a Ciência e Tecnologia PTDC/MED-TOX/30418/2017Fundação para a Ciência e Tecnologia SFRH/BD/131331/2017iNOVA4Health UID/Multi/04462/2013
6 · The paper itself

Abstract

In this review encouraged by original data, we first provided in vivo evidence that the kidney, comparative to the liver or brain, is an organ particularly rich in cysteine. In the kidney, the total availability of cysteine was higher in cortex tissue than in the medulla and distributed in free reduced, free oxidized and protein-bound fractions (in descending order). Next, we provided a comprehensive integrated review on the evidence that supports the reliance on cysteine of the kidney beyond cysteine antioxidant properties, highlighting the relevance of cysteine and its renal metabolism in the control of cysteine excess in the body as a pivotal source of metabolites to kidney biomass and bioenergetics and a promoter of adaptive responses to stressors. This view might translate into novel perspectives on the mechanisms of kidney function and blood pressure regulation and on clinical implications of the

Indexed as

Precision MedicineBrainCysteineHumansKidneyLiverOrgan SpecificityCysteinebioenergeticscysteine-related thiolomecysteine transportersferroptosisglutathioneH2Shypertensionhypoxiakidney metabolismlysosomes

Identifiers

PMID35209204
PMCPMC8874463
OpenAlexW4214502763

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.